KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,740,509 | -28.0% | 365,134 | -7.7% | 0.02% | -22.7% |
Q2 2023 | $85,776,535 | +41.8% | 395,557 | +18.8% | 0.02% | +29.4% |
Q1 2023 | $60,477,947 | +1.4% | 332,955 | +9.7% | 0.02% | 0.0% |
Q4 2022 | $59,637,949 | -13.6% | 303,501 | -1.1% | 0.02% | -22.7% |
Q3 2022 | $69,029,000 | +4083.6% | 306,895 | +2253.3% | 0.02% | – |
Q2 2022 | $1,650,000 | +7.0% | 13,041 | +7.2% | 0.00% | – |
Q1 2022 | $1,542,000 | +0.6% | 12,163 | +4.0% | 0.00% | – |
Q4 2021 | $1,533,000 | -0.5% | 11,696 | -7.1% | 0.00% | – |
Q3 2021 | $1,540,000 | +22.9% | 12,585 | +14.5% | 0.00% | – |
Q2 2021 | $1,253,000 | +73.3% | 10,990 | +82.8% | 0.00% | – |
Q1 2021 | $723,000 | +120.4% | 6,012 | +86.0% | 0.00% | – |
Q4 2020 | $328,000 | -97.4% | 3,232 | -97.1% | 0.00% | -100.0% |
Q2 2020 | $12,413,000 | – | 111,365 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |